Request for Covid-19 Impact Assessment of this Report
The United States Bifidobacterium Longum market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bifidobacterium Longum market, reaching US$ million by the year 2028. As for the Europe Bifidobacterium Longum landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Bifidobacterium Longum players cover ATCC Inc, BioGaia AB, Mystic Pharmaceuticals Inc, and Hanson Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bifidobacterium Longum market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
0.2g/Piece
0.25g/Piece
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Medicine
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
ATCC Inc
BioGaia AB
Mystic Pharmaceuticals Inc
Hanson Ltd
Biofodan A/S
BioCare Copenhagen ApS
Danisco A/S
Danone SA
Deerland Enzymes Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bifidobacterium Longum Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bifidobacterium Longum by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bifidobacterium Longum by Country/Region, 2017, 2022 & 2028
2.2 Bifidobacterium Longum Segment by Type
2.2.1 0.2g/Piece
2.2.2 0.25g/Piece
2.3 Bifidobacterium Longum Sales by Type
2.3.1 Global Bifidobacterium Longum Sales Market Share by Type (2017-2022)
2.3.2 Global Bifidobacterium Longum Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bifidobacterium Longum Sale Price by Type (2017-2022)
2.4 Bifidobacterium Longum Segment by Application
2.4.1 Medicine
2.4.2 Others
2.5 Bifidobacterium Longum Sales by Application
2.5.1 Global Bifidobacterium Longum Sale Market Share by Application (2017-2022)
2.5.2 Global Bifidobacterium Longum Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bifidobacterium Longum Sale Price by Application (2017-2022)
3 Global Bifidobacterium Longum by Company
3.1 Global Bifidobacterium Longum Breakdown Data by Company
3.1.1 Global Bifidobacterium Longum Annual Sales by Company (2020-2022)
3.1.2 Global Bifidobacterium Longum Sales Market Share by Company (2020-2022)
3.2 Global Bifidobacterium Longum Annual Revenue by Company (2020-2022)
3.2.1 Global Bifidobacterium Longum Revenue by Company (2020-2022)
3.2.2 Global Bifidobacterium Longum Revenue Market Share by Company (2020-2022)
3.3 Global Bifidobacterium Longum Sale Price by Company
3.4 Key Manufacturers Bifidobacterium Longum Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bifidobacterium Longum Product Location Distribution
3.4.2 Players Bifidobacterium Longum Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bifidobacterium Longum by Geographic Region
4.1 World Historic Bifidobacterium Longum Market Size by Geographic Region (2017-2022)
4.1.1 Global Bifidobacterium Longum Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bifidobacterium Longum Annual Revenue by Geographic Region
4.2 World Historic Bifidobacterium Longum Market Size by Country/Region (2017-2022)
4.2.1 Global Bifidobacterium Longum Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bifidobacterium Longum Annual Revenue by Country/Region
4.3 Americas Bifidobacterium Longum Sales Growth
4.4 APAC Bifidobacterium Longum Sales Growth
4.5 Europe Bifidobacterium Longum Sales Growth
4.6 Middle East & Africa Bifidobacterium Longum Sales Growth
5 Americas
5.1 Americas Bifidobacterium Longum Sales by Country
5.1.1 Americas Bifidobacterium Longum Sales by Country (2017-2022)
5.1.2 Americas Bifidobacterium Longum Revenue by Country (2017-2022)
5.2 Americas Bifidobacterium Longum Sales by Type
5.3 Americas Bifidobacterium Longum Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bifidobacterium Longum Sales by Region
6.1.1 APAC Bifidobacterium Longum Sales by Region (2017-2022)
6.1.2 APAC Bifidobacterium Longum Revenue by Region (2017-2022)
6.2 APAC Bifidobacterium Longum Sales by Type
6.3 APAC Bifidobacterium Longum Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bifidobacterium Longum by Country
7.1.1 Europe Bifidobacterium Longum Sales by Country (2017-2022)
7.1.2 Europe Bifidobacterium Longum Revenue by Country (2017-2022)
7.2 Europe Bifidobacterium Longum Sales by Type
7.3 Europe Bifidobacterium Longum Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bifidobacterium Longum by Country
8.1.1 Middle East & Africa Bifidobacterium Longum Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bifidobacterium Longum Revenue by Country (2017-2022)
8.2 Middle East & Africa Bifidobacterium Longum Sales by Type
8.3 Middle East & Africa Bifidobacterium Longum Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bifidobacterium Longum
10.3 Manufacturing Process Analysis of Bifidobacterium Longum
10.4 Industry Chain Structure of Bifidobacterium Longum
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bifidobacterium Longum Distributors
11.3 Bifidobacterium Longum Customer
12 World Forecast Review for Bifidobacterium Longum by Geographic Region
12.1 Global Bifidobacterium Longum Market Size Forecast by Region
12.1.1 Global Bifidobacterium Longum Forecast by Region (2023-2028)
12.1.2 Global Bifidobacterium Longum Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bifidobacterium Longum Forecast by Type
12.7 Global Bifidobacterium Longum Forecast by Application
13 Key Players Analysis
13.1 ATCC Inc
13.1.1 ATCC Inc Company Information
13.1.2 ATCC Inc Bifidobacterium Longum Product Offered
13.1.3 ATCC Inc Bifidobacterium Longum Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ATCC Inc Main Business Overview
13.1.5 ATCC Inc Latest Developments
13.2 BioGaia AB
13.2.1 BioGaia AB Company Information
13.2.2 BioGaia AB Bifidobacterium Longum Product Offered
13.2.3 BioGaia AB Bifidobacterium Longum Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 BioGaia AB Main Business Overview
13.2.5 BioGaia AB Latest Developments
13.3 Mystic Pharmaceuticals Inc
13.3.1 Mystic Pharmaceuticals Inc Company Information
13.3.2 Mystic Pharmaceuticals Inc Bifidobacterium Longum Product Offered
13.3.3 Mystic Pharmaceuticals Inc Bifidobacterium Longum Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mystic Pharmaceuticals Inc Main Business Overview
13.3.5 Mystic Pharmaceuticals Inc Latest Developments
13.4 Hanson Ltd
13.4.1 Hanson Ltd Company Information
13.4.2 Hanson Ltd Bifidobacterium Longum Product Offered
13.4.3 Hanson Ltd Bifidobacterium Longum Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Hanson Ltd Main Business Overview
13.4.5 Hanson Ltd Latest Developments
13.5 Biofodan A/S
13.5.1 Biofodan A/S Company Information
13.5.2 Biofodan A/S Bifidobacterium Longum Product Offered
13.5.3 Biofodan A/S Bifidobacterium Longum Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biofodan A/S Main Business Overview
13.5.5 Biofodan A/S Latest Developments
13.6 BioCare Copenhagen ApS
13.6.1 BioCare Copenhagen ApS Company Information
13.6.2 BioCare Copenhagen ApS Bifidobacterium Longum Product Offered
13.6.3 BioCare Copenhagen ApS Bifidobacterium Longum Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 BioCare Copenhagen ApS Main Business Overview
13.6.5 BioCare Copenhagen ApS Latest Developments
13.7 Danisco A/S
13.7.1 Danisco A/S Company Information
13.7.2 Danisco A/S Bifidobacterium Longum Product Offered
13.7.3 Danisco A/S Bifidobacterium Longum Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Danisco A/S Main Business Overview
13.7.5 Danisco A/S Latest Developments
13.8 Danone SA
13.8.1 Danone SA Company Information
13.8.2 Danone SA Bifidobacterium Longum Product Offered
13.8.3 Danone SA Bifidobacterium Longum Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Danone SA Main Business Overview
13.8.5 Danone SA Latest Developments
13.9 Deerland Enzymes Inc.
13.9.1 Deerland Enzymes Inc. Company Information
13.9.2 Deerland Enzymes Inc. Bifidobacterium Longum Product Offered
13.9.3 Deerland Enzymes Inc. Bifidobacterium Longum Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Deerland Enzymes Inc. Main Business Overview
13.9.5 Deerland Enzymes Inc. Latest Developments
14 Research Findings and Conclusion
Table 1. Bifidobacterium Longum Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Bifidobacterium Longum Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.2g/Piece
Table 4. Major Players of 0.25g/Piece
Table 5. Global Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Bifidobacterium Longum Sales Market Share by Type (2017-2022)
Table 7. Global Bifidobacterium Longum Revenue by Type (2017-2022) & ($ million)
Table 8. Global Bifidobacterium Longum Revenue Market Share by Type (2017-2022)
Table 9. Global Bifidobacterium Longum Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Bifidobacterium Longum Sales Market Share by Application (2017-2022)
Table 12. Global Bifidobacterium Longum Revenue by Application (2017-2022)
Table 13. Global Bifidobacterium Longum Revenue Market Share by Application (2017-2022)
Table 14. Global Bifidobacterium Longum Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Bifidobacterium Longum Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Bifidobacterium Longum Sales Market Share by Company (2020-2022)
Table 17. Global Bifidobacterium Longum Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Bifidobacterium Longum Revenue Market Share by Company (2020-2022)
Table 19. Global Bifidobacterium Longum Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Bifidobacterium Longum Producing Area Distribution and Sales Area
Table 21. Players Bifidobacterium Longum Products Offered
Table 22. Bifidobacterium Longum Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bifidobacterium Longum Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Bifidobacterium Longum Sales Market Share Geographic Region (2017-2022)
Table 27. Global Bifidobacterium Longum Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Bifidobacterium Longum Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Bifidobacterium Longum Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Bifidobacterium Longum Sales Market Share by Country/Region (2017-2022)
Table 31. Global Bifidobacterium Longum Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Bifidobacterium Longum Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Bifidobacterium Longum Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Bifidobacterium Longum Sales Market Share by Country (2017-2022)
Table 35. Americas Bifidobacterium Longum Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Bifidobacterium Longum Revenue Market Share by Country (2017-2022)
Table 37. Americas Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Bifidobacterium Longum Sales Market Share by Type (2017-2022)
Table 39. Americas Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Bifidobacterium Longum Sales Market Share by Application (2017-2022)
Table 41. APAC Bifidobacterium Longum Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Bifidobacterium Longum Sales Market Share by Region (2017-2022)
Table 43. APAC Bifidobacterium Longum Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Bifidobacterium Longum Revenue Market Share by Region (2017-2022)
Table 45. APAC Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Bifidobacterium Longum Sales Market Share by Type (2017-2022)
Table 47. APAC Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Bifidobacterium Longum Sales Market Share by Application (2017-2022)
Table 49. Europe Bifidobacterium Longum Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Bifidobacterium Longum Sales Market Share by Country (2017-2022)
Table 51. Europe Bifidobacterium Longum Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Bifidobacterium Longum Revenue Market Share by Country (2017-2022)
Table 53. Europe Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Bifidobacterium Longum Sales Market Share by Type (2017-2022)
Table 55. Europe Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Bifidobacterium Longum Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Bifidobacterium Longum Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Bifidobacterium Longum Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Bifidobacterium Longum Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Bifidobacterium Longum Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Bifidobacterium Longum Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Bifidobacterium Longum Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Bifidobacterium Longum
Table 66. Key Market Challenges & Risks of Bifidobacterium Longum
Table 67. Key Industry Trends of Bifidobacterium Longum
Table 68. Bifidobacterium Longum Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Bifidobacterium Longum Distributors List
Table 71. Bifidobacterium Longum Customer List
Table 72. Global Bifidobacterium Longum Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Bifidobacterium Longum Sales Market Forecast by Region
Table 74. Global Bifidobacterium Longum Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Bifidobacterium Longum Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Bifidobacterium Longum Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Bifidobacterium Longum Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Bifidobacterium Longum Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Bifidobacterium Longum Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Bifidobacterium Longum Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Bifidobacterium Longum Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Bifidobacterium Longum Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Bifidobacterium Longum Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Bifidobacterium Longum Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Bifidobacterium Longum Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Bifidobacterium Longum Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Bifidobacterium Longum Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Bifidobacterium Longum Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Bifidobacterium Longum Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Bifidobacterium Longum Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Bifidobacterium Longum Revenue Market Share Forecast by Application (2023-2028)
Table 92. ATCC Inc Basic Information, Bifidobacterium Longum Manufacturing Base, Sales Area and Its Competitors
Table 93. ATCC Inc Bifidobacterium Longum Product Offered
Table 94. ATCC Inc Bifidobacterium Longum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. ATCC Inc Main Business
Table 96. ATCC Inc Latest Developments
Table 97. BioGaia AB Basic Information, Bifidobacterium Longum Manufacturing Base, Sales Area and Its Competitors
Table 98. BioGaia AB Bifidobacterium Longum Product Offered
Table 99. BioGaia AB Bifidobacterium Longum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. BioGaia AB Main Business
Table 101. BioGaia AB Latest Developments
Table 102. Mystic Pharmaceuticals Inc Basic Information, Bifidobacterium Longum Manufacturing Base, Sales Area and Its Competitors
Table 103. Mystic Pharmaceuticals Inc Bifidobacterium Longum Product Offered
Table 104. Mystic Pharmaceuticals Inc Bifidobacterium Longum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Mystic Pharmaceuticals Inc Main Business
Table 106. Mystic Pharmaceuticals Inc Latest Developments
Table 107. Hanson Ltd Basic Information, Bifidobacterium Longum Manufacturing Base, Sales Area and Its Competitors
Table 108. Hanson Ltd Bifidobacterium Longum Product Offered
Table 109. Hanson Ltd Bifidobacterium Longum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Hanson Ltd Main Business
Table 111. Hanson Ltd Latest Developments
Table 112. Biofodan A/S Basic Information, Bifidobacterium Longum Manufacturing Base, Sales Area and Its Competitors
Table 113. Biofodan A/S Bifidobacterium Longum Product Offered
Table 114. Biofodan A/S Bifidobacterium Longum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Biofodan A/S Main Business
Table 116. Biofodan A/S Latest Developments
Table 117. BioCare Copenhagen ApS Basic Information, Bifidobacterium Longum Manufacturing Base, Sales Area and Its Competitors
Table 118. BioCare Copenhagen ApS Bifidobacterium Longum Product Offered
Table 119. BioCare Copenhagen ApS Bifidobacterium Longum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. BioCare Copenhagen ApS Main Business
Table 121. BioCare Copenhagen ApS Latest Developments
Table 122. Danisco A/S Basic Information, Bifidobacterium Longum Manufacturing Base, Sales Area and Its Competitors
Table 123. Danisco A/S Bifidobacterium Longum Product Offered
Table 124. Danisco A/S Bifidobacterium Longum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. Danisco A/S Main Business
Table 126. Danisco A/S Latest Developments
Table 127. Danone SA Basic Information, Bifidobacterium Longum Manufacturing Base, Sales Area and Its Competitors
Table 128. Danone SA Bifidobacterium Longum Product Offered
Table 129. Danone SA Bifidobacterium Longum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. Danone SA Main Business
Table 131. Danone SA Latest Developments
Table 132. Deerland Enzymes Inc. Basic Information, Bifidobacterium Longum Manufacturing Base, Sales Area and Its Competitors
Table 133. Deerland Enzymes Inc. Bifidobacterium Longum Product Offered
Table 134. Deerland Enzymes Inc. Bifidobacterium Longum Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Deerland Enzymes Inc. Main Business
Table 136. Deerland Enzymes Inc. Latest Developments
List of Figures
Figure 1. Picture of Bifidobacterium Longum
Figure 2. Bifidobacterium Longum Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bifidobacterium Longum Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Bifidobacterium Longum Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Bifidobacterium Longum Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.2g/Piece
Figure 10. Product Picture of 0.25g/Piece
Figure 11. Global Bifidobacterium Longum Sales Market Share by Type in 2021
Figure 12. Global Bifidobacterium Longum Revenue Market Share by Type (2017-2022)
Figure 13. Bifidobacterium Longum Consumed in Medicine
Figure 14. Global Bifidobacterium Longum Market: Medicine (2017-2022) & (K Pcs)
Figure 15. Bifidobacterium Longum Consumed in Others
Figure 16. Global Bifidobacterium Longum Market: Others (2017-2022) & (K Pcs)
Figure 17. Global Bifidobacterium Longum Sales Market Share by Application (2017-2022)
Figure 18. Global Bifidobacterium Longum Revenue Market Share by Application in 2021
Figure 19. Bifidobacterium Longum Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Bifidobacterium Longum Revenue Market Share by Company in 2021
Figure 21. Global Bifidobacterium Longum Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Bifidobacterium Longum Revenue Market Share by Geographic Region in 2021
Figure 23. Global Bifidobacterium Longum Sales Market Share by Region (2017-2022)
Figure 24. Global Bifidobacterium Longum Revenue Market Share by Country/Region in 2021
Figure 25. Americas Bifidobacterium Longum Sales 2017-2022 (K Pcs)
Figure 26. Americas Bifidobacterium Longum Revenue 2017-2022 ($ Millions)
Figure 27. APAC Bifidobacterium Longum Sales 2017-2022 (K Pcs)
Figure 28. APAC Bifidobacterium Longum Revenue 2017-2022 ($ Millions)
Figure 29. Europe Bifidobacterium Longum Sales 2017-2022 (K Pcs)
Figure 30. Europe Bifidobacterium Longum Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Bifidobacterium Longum Sales 2017-2022 (K Pcs)
Figure 32. Middle East & Africa Bifidobacterium Longum Revenue 2017-2022 ($ Millions)
Figure 33. Americas Bifidobacterium Longum Sales Market Share by Country in 2021
Figure 34. Americas Bifidobacterium Longum Revenue Market Share by Country in 2021
Figure 35. United States Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Bifidobacterium Longum Sales Market Share by Region in 2021
Figure 40. APAC Bifidobacterium Longum Revenue Market Share by Regions in 2021
Figure 41. China Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Bifidobacterium Longum Sales Market Share by Country in 2021
Figure 48. Europe Bifidobacterium Longum Revenue Market Share by Country in 2021
Figure 49. Germany Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Bifidobacterium Longum Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Bifidobacterium Longum Revenue Market Share by Country in 2021
Figure 56. Egypt Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Bifidobacterium Longum Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Bifidobacterium Longum in 2021
Figure 62. Manufacturing Process Analysis of Bifidobacterium Longum
Figure 63. Industry Chain Structure of Bifidobacterium Longum
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...